Clinical Trials Directory

Trials / Completed

CompletedNCT01846234

Sodium Intake in Multiple Sclerosis

Effect of Sodium Intake in Multiple Sclerosis Disease Activity

Status
Completed
Phase
Study type
Observational
Enrollment
132 (actual)
Sponsor
Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Recently, it has been shown that salt (ClNa, sodium chloride) can modulate the differentiation of human and mouse TH17 cells. Indeed, mice feed with high sodium diet were described to develop more aggressive course of EAE (Experimental Autoimmune Encephalitis). However, the role of sodium intake in MS has not been investigated. In this study we investigate the effect of sodium intake in Multiple Sclerosis (MS) clinical and radiological activity.

Conditions

Timeline

Start date
2010-11-01
Primary completion
2013-07-01
Completion
2013-07-01
First posted
2013-05-03
Last updated
2013-10-22

Locations

1 site across 1 country: Argentina

Source: ClinicalTrials.gov record NCT01846234. Inclusion in this directory is not an endorsement.